Kenneth P. H. Pritzker

Fondatore presso Rna Diagnostics, Inc.

Health Services

Health Technology

Profilo

Kenneth P.
H.
Pritzker is the founder and director of RNA Diagnostics, Inc. which is founded in 2010.
He also held a director position at CareRx Corp.
in 2009.

Posizioni attive di Kenneth P. H. Pritzker

Società	Posizione	Inizio
Rna Diagnostics, Inc. Rna Diagnostics, Inc. Medical SpecialtiesHealth Technology Rna Diagnostics, Inc. operates as a cancer diagnostics company which builds a platform of prognostic biomarker tools to help improve the lives of patients undergoing chemotherapy. The firm develops prognostic biomarker tools to improve the lives of women undergoing chemotherapy for breast cancer. It provides The RNA Disruption Assay (RDA), which provides physicians with an evaluation of how individual patients are responding to chemotherapy. The company was founded by Kenneth P. H. Pritzker in 2010 and is headquartered in Toronto, Canada.	Fondatore	01/01/2010

Tutte le posizioni attive di Kenneth P. H. Pritzker

Precedenti posizioni note di Kenneth P. H. Pritzker

Società	Posizione	Fine
CARERX CORPORATION	Direttore/Membro del Consiglio	25/06/2009

Vedi nel dettaglio l'esperienza di Kenneth P. H. Pritzker

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di Kenneth P. H. Pritzker

Relazioni

Relazioni di 1° grado

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Società quotate in Borsa	1
CARERX CORPORATION	Health Services

Aziende private	1
Rna Diagnostics, Inc. Rna Diagnostics, Inc. Medical SpecialtiesHealth Technology Rna Diagnostics, Inc. operates as a cancer diagnostics company which builds a platform of prognostic biomarker tools to help improve the lives of patients undergoing chemotherapy. The firm develops prognostic biomarker tools to improve the lives of women undergoing chemotherapy for breast cancer. It provides The RNA Disruption Assay (RDA), which provides physicians with an evaluation of how individual patients are responding to chemotherapy. The company was founded by Kenneth P. H. Pritzker in 2010 and is headquartered in Toronto, Canada.	Health Technology